ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 664885 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 664885; 2) Community: the network communities that were significantly associated with the response to NSC 664885; 3) Molecule: the relationships between components within communities and NSC 664885; 4) MDR: the compounds that were significantly associated with the NSC 664885.

NSC Compound Enrichment Correlation
NSC 700862 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- 0.011265111688021 0.408279
NSC 703784 L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride 0.011265111688021 0.031943147
NSC 715407 Null 0.011265111688021 0.25650185
NSC 718781 Erlotinib hydrochloride 0.011265111688021 -0.33061069
NSC 726089 11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate 0.011265111688021 0.40748552
NSC 726578 Null 0.011265111688021 0.16542587
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.011265111688021 0.17510613
NSC 744688 Null 0.011265111688021 0.3649597
NSC 749600 Null 0.011265111688021 0.25923446
NSC 753456 2-4-[5-(3,5-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,6,7-trimethoxy-1,3-benzothiazole 0.011265111688021 0.23193336
Total:138  Current:57    [First] [Prev] [Next] [Last]